KLAR
Sign in
Klaria Pharma Holding AB
Save
48.49M
Market cap
–
Current P/E
1.95x
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression.
Similar securities
Based on sector and market capitalization
Report issue